|
1
|
Misra S, Chaturvedi A and Misra NC: Penile
carcinoma: A challenge for the developing world. Lancet Oncol.
5:240–247. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Montella M, Sabetta R, Ronchi A, De Sio M,
Arcaniolo D, De Vita F, Tirino G, Caputo A, D'Antonio A, Fiorentino
F, et al: Immunotherapy in penile squamous cell carcinoma: Present
or future? Multi-target analysis of programmed cell death ligand 1
expression and microsatellite instability. Front Med (Lausanne).
9:8742132022. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sirithanaphol W, Sookprasert A,
Rompsaithong U, Kiatsopit P, Wirasorn K and Chindaprasirt J:
Prognostic factors for penile cancer and survival in response to
multimodality therapy. Res Rep Urol. 12:29–34. 2020.PubMed/NCBI
|
|
4
|
Rippentrop JM, Joslyn SA and Konety BR:
Squamous cell carcinoma of the penis: Evaluation of data from the
surveillance, epidemiology, and end results program. Cancer.
101:1357–1363. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Paiva GR, de Oliveira Araújo IB, Athanazio
DA and de Freitas LAR: Penile cancer: Impact of age at diagnosis on
morphology and prognosis. Int Urol Nephrol. 47:295–299. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu W, Luo Y, Wang G, Li N, Wang Z, Lei J
and Wang X: Conditional survival after surgery for patients with
penile cancer. Andrology. 8:1744–1752. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Emmanuel A and Watkin N: Update on organ
preserving surgical strategies for penile cancer. Urol Oncol.
40:179–183. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
McDougal WS: Phallic preserving surgery in
patients with invasive squamous cell carcinoma of the penis. J
Urol. 174:2218–2220. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nam JK, Lee DH, Park SW, Kam SC, Lee KS,
Kim TH, Kim TS, Oh CK, Park HJ and Kim TN: Clinicopathologic
characteristics and treatment outcomes of penile cancer. World J
Mens Health. 35:28–33. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Agrawal A, Pai D, Ananthakrishnan N, Smile
SR and Ratnakar C: The histological extent of the local spread of
carcinoma of the penis and its therapeutic implications. BJU Int.
85:299–301. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hoffman MA, Renshaw AA and Loughlin KR:
Squamous cell carcinoma of the penis and microscopic pathologic
margins: How much margin is needed for local cure? Cancer.
85:1565–1568. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Minhas S, Kayes O, Hegarty P, Kumar P,
Freeman A and Ralph D: What surgical resection margins are required
to achieve oncological control in men with primary penile cancer?
BJU Int. 96:1040–1043. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sri D, Sujenthiran A, Lam W, Minter J,
Tinwell BE, Corbishley CM, Yap T, Sharma DM, Ayres BE and Watkin
NW: A study into the association between local recurrence rates and
surgical resection margins in organ-sparing surgery for penile
squamous cell cancer. BJU Int. 122:576–582. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lindner AK, Schachtner G, Steiner E,
Kroiss A, Uprimny C, Steinkohl F, Horninger W, Heidegger I,
Madersbacher S and Pichler R: Organ-sparing surgery of penile
cancer: Higher rate of local recurrence yet no impact on overall
survival. World J Urol. 38:417–424. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miyamoto H: Clinical benefits of frozen
section assessment during urological surgery: Does it contribute to
improving surgical margin status and patient outcomes as previously
thought? Int J Urol. 24:25–31. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pettaway CA, Srigley JR, Brookland RK,
Choyke PL and Amin MB: Penis. Amin MB, Edge SB, Greene FL, et al:
AJCC cancer staging manual. 8th edition. New York: Springer; pp.
pp7012017
|
|
17
|
Lee AYY: Anticoagulant therapy for venous
thromboembolism in cancer. N Engl J Med. 382:1650–1652. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang FM and Xing NZ: Systemic coagulation
markers especially fibrinogen are closely associated with the
aggressiveness of prostate cancer in patients who underwent
transrectal ultrasound-guided prostate biopsy. Dis Markers.
2021:88999942021.PubMed/NCBI
|
|
19
|
Bates SM, Greer IA, Middeldorp S, Veenstra
DL, Prabulos AM and Vandvik PO: VTE, thrombophilia, antithrombotic
therapy, and pregnancy: Antithrombotic therapy and prevention of
thrombosis, 9th ed: American college of chest physicians
evidence-based clinical practice guidelines. Chest. 141 (2
Suppl):e691S–e736S. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Winters J and Garcia D: Cancer-associated
thrombosis. Hematol Oncol Clin North Am. 24695–707. (viii)2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
O'Leary JG, Greenberg CS, Patton HM and
Caldwell SH: AGA Clinical practice update: Coagulation in
cirrhosis. Gastroenterology. 157:34–43.e1. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chahoud J, Kohli M and Spiess PE:
Management of advanced penile cancer. Mayo Clin Proc. 96:720–732.
2021. View Article : Google Scholar : PubMed/NCBI
|
